Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11365183
Eicosanoid derivatives
granted -
US 11364293
Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens
granted -
US 11364261
Alleviating common cold and influenza symptoms with molecular hydrogen
granted -
US 11364260
Methods and compositions for administration of iron
granted -
US 11364228
Gaboxadol for therapeutic treatment of 1p36 deletion syndrome
granted -
US 11364227
Sphingosine kinase 2 inhibitor for treating coronavirus infection
granted -
US 11364215
GHB formulation and method for its manufacture
granted -
US 11364240
Pyruvate kinase activators for use in treating blood disorders
granted -
US 11357872
Imaging neurotransmitters in vivo using functionalized carbon nanotubes
granted -
US 11358965
EGFR dimer disruptors and use of the same
granted -
US 11359246
Treatment of obesity with G-protein coupled receptor 75 (GPR75) inhibitors
granted -
US 11359204
Chimeric antigen receptors targeting B-cell maturation antigen
granted -
US 11359195
Method for identifying antibiotic targets
granted -
US 11358991
Heme sequesting peptides and uses therefor
granted -
US 11358977
Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels
granted -
US 11358940
K-Ras modulators
granted -
US 11358947
Substituted 2-acylamino-cycloalkylthiophene-3-carboxylic acid arylamides as inhibitors of calcium-activated chloride channel TMEM16A
granted -
US 11358931
Selective androgen receptor modulators (SARMs) and uses thereof
granted -
US 11357870
Codon optimized REP1 genes and uses thereof
granted -
US 11357842
PD-L1 targeting DNA vaccine for cancer immunotherapy
granted -
US 11357854
Pharmaceutical compositions comprising meloxicam
granted -
US 11357848
Methods of rational nicotine hapten design and uses thereof
granted -
US 11357839
Brachyury protein, non-poxvirus non-yeast vectors encoding Brachyury protein, and their use
granted -
US 11357832
Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of iduronate-2-sulfatase
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.